Home / Latest Reports / Endometriosis Treatment Market

Endometriosis Treatment Market By Drug Type (Progestin, Gonadotropins Releasing Hormone agonists (GRH), Oral contraceptive pills and Non-Steroidal Anti-Inflammatory drugs (NSAIDs)); Treatment Type (Hormonal Therapies and Pain management); and Distribution Channel (Mail Order Pharmacies, Hospital Pharmacies, E-commerce, Retail Pharmacies, Drugstores and Others); - Global Industry Analysis And Forecast To 2027

Published On : August 2018 Pages : 180 Category: Healthcare IT Report Code : HC081203

Request Sample Inquiry Before Buying Request for Customization Check Discount

Industry Outlook

Endometriosis is a painful disorder, in which tissues supporting the inside walls of uterus start growing on the outside walls of the uterus, the parts such as tissue lining of pelvis, ovary and fallopian tubes are affected in Endometriosis. The tissue on the outside wall of uterus starts acting as normal tissue, it thickens and breaks down, causing bleeding with each mensuration cycle. Endometriosis causes severe pain during mensuration and fertility problems can also develop. Millions of females all over the world suffer from Endometriosis disorder, but are neglecting treatments in less developed economies. To avoid the adverse effect of Endometriosis disorder that is infertility, women take the option to treatments even sometimes surgery. Knowledge regarding Endometriosis disorder is increasing in women which is making them opt treatment, rising reproductive age group and technological developments in the Endometriosis field are fueling the need for treatment against Endometriosis. Therefore these are the factors that, the Endometriosis Treatment Market is anticipated to expand and has tremendous scope during the forecast period. The global Endometriosis Treatment Market is anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Endometriosis Treatment Market is based on segment, by Drug Type the market is segmented into Progestin, Gonadotropins Releasing Hormone agonists (GRH), Oral contraceptive pills and Non-Steroidal Anti-Inflammatory drugs (NSAIDs); by Treatment Type the market is segmented into Hormonal Therapies and Pain management and by Distribution Channel the market is segmented into Mail Order Pharmacies, Hospital Pharmacies, E-commerce, Retail Pharmacies, Drugstores and Others.

  • Endometriosis Treatment Market, By Drug Type
  • Progestin
  • Gonadotropins Releasing Hormone agonists (GRH)
  • Oral contraceptive pills
  • Non-Steroidal Anti-Inflammatory drugs (NSAIDs)
  • Endometriosis Treatment Market, By Treatment Type
  • Hormonal Therapies
  • Pain management
  • Endometriosis Treatment Market, By Distribution Channel
  • Mail Order Pharmacies
  • Hospital Pharmacies
  • E-commerce
  • Retail Pharmacies
  • Drugstores
  • Others

Regional Insights

On a global front, the Endometriosis Treatment Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, South Africa, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Endometriosis Treatment Market in case of revenue due to factors like; more cots of treatment, more number of people diagnosed with endometriosis, etc.

Endometriosis Treatment Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are Takeda Pharmaceutical Company, Neurocrine Biosciences Inc., Eli Lilly and company, AstraZeneca Plc., Bayer AG, Pfizer Inc., Meditrina Pharmaceuticals, Astellas Pharma, and Abbvie. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • Takeda Pharmaceutical Company
  • Neurocrine Biosciences Inc.
  • Eli Lilly and company
  • AstraZeneca Plc.
  • Bayer AG
  • Pfizer Inc.
  • Meditrina Pharmaceuticals
  • Astellas Pharma
  • Abbvie American orthodontic

Some of the key questions answered by the report are:

  • What was the market size in 2017 and forecast from 2017 to 2023?
  • What will be the industry market growth from 2017 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Endometriosis Treatment Market, By Drug Type, Estimates and Forecast, 2017-2027 ($Million)

o   Progestin

o   Gonadotropins Releasing Hormone agonists (GRH)

o   Oral contraceptive pills

o   Non-Steroidal Anti-Inflammatory drugs (NSAIDs)

o   Endometriosis Treatment Market, By Treatment Type, Estimates and Forecast, 2017-2027 ($Million)

o   Hormonal Therapies

o   Pain management

o   Endometriosis Treatment Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)

o   Mail Order Pharmacies

o   Hospital Pharmacies

o   E-commerce

o   Retail Pharmacies

o   Drugstores

o   Others

Endometriosis Treatment Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Endometriosis Treatment Market, By Country

o   U.S. Endometriosis Treatment Market

o   Canada Endometriosis Treatment Market

o   Mexico Endometriosis Treatment Market

o   Europe

§  Europe Endometriosis Treatment Market, By Country

o   Germany Endometriosis Treatment Market

o   UK Endometriosis Treatment Market

o   France Endometriosis Treatment Market

o   Russia Endometriosis Treatment Market

o   Italy Endometriosis Treatment Market

o   Rest of Europe Endometriosis Treatment Market

o   Asia-Pacific

§  Asia-Pacific Endometriosis Treatment Market, By Country

o   China Endometriosis Treatment Market

o   Japan Endometriosis Treatment Market

o   South Korea  Endometriosis Treatment Market

o   India Endometriosis Treatment Market

o   Southeast Asia Endometriosis Treatment Market

o   Rest of Asia-Pacific Endometriosis Treatment Market

o   South America

§  South America Endometriosis Treatment Market, By Country

o   Brazil Endometriosis Treatment Market

o   Argentina Endometriosis Treatment Market

o   Columbia Endometriosis Treatment Market

o   Rest of South America Endometriosis Treatment Market

o   Middle East and Africa

§  Middle East and Africa Endometriosis Treatment Market, By Country

o   Saudi Arabia Endometriosis Treatment Market

o   UAE Endometriosis Treatment Market

o   Egypt Endometriosis Treatment Market

o   Nigeria Endometriosis Treatment Market

o   South Africa Endometriosis Treatment Market

o   Rest of MEA Endometriosis Treatment Market

Table of Contents

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Endometriosis Treatment Market, By Drug Type

5.1.     Introduction

5.2.     Global Endometriosis Treatment Revenue and Market Share by Drug Type (2017-2027)

5.2.1.  Global Endometriosis Treatment Revenue and Revenue Share by Drug Type (2017-2027)

5.3.     Progestin

5.3.1.  Global Progestin Revenue and Growth Rate (2017-2027)

5.4.     Gonadotropins Releasing Hormone agonists (GRH)

5.4.1.  Global Gonadotropins Releasing Hormone agonists (GRH) Revenue and Growth Rate (2017-2027)

5.5.     Oral contraceptive pills

5.5.1.  Global Oral contraceptive pills  Revenue and Growth Rate (2017-2027)

5.6.     Non-Steroidal Anti-Inflammatory drugs (NSAIDs)

5.6.1.  Global Non-Steroidal Anti-Inflammatory drugs (NSAIDs) Revenue and Growth Rate (2017-2027)

6.       Endometriosis Treatment Market, By Treatment Type

6.1.     Introduction

6.2.     Global Endometriosis Treatment Revenue and Market Share by Treatment Type (2017-2027)

6.2.1.  Global Endometriosis Treatment Revenue and Revenue Share by Treatment Type (2017-2027)

6.3.     Hormonal Therapies

6.3.1.  Global Hormonal Therapies Revenue and Growth Rate (2017-2027)

6.4.     Pain management

6.4.1.  Global Pain management Revenue and Growth Rate (2017-2027)

7.       Endometriosis Treatment Market, By Distribution Channel

7.1.     Introduction

7.2.     Global Endometriosis Treatment Revenue and Market Share by Distribution Channel (2017-2027)

7.2.1.  Global Endometriosis Treatment Revenue and Revenue Share by Distribution Channel (2017-2027)

7.3.     Mail Order Pharmacies

7.3.1.  Global Mail Order Pharmacies Revenue and Growth Rate (2017-2027)

7.4.     Hospital Pharmacies

7.4.1.  Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)

7.5.     E-commerce

7.5.1.  Global E-commerce Revenue and Growth Rate (2017-2027)

7.6.     Retail Pharmacies

7.6.1.  Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

7.7.     Drugstores

7.7.1.  Global Drugstores  Revenue and Growth Rate (2017-2027)

7.8.     Others

7.8.1.  Global Others Revenue and Growth Rate (2017-2027)

8.       Endometriosis Treatment Market, By Region

8.1.     Introduction

8.2.     Global Endometriosis Treatment Revenue and Market Share by Regions

8.2.1.  Global Endometriosis Treatment Revenue by Regions (2017-2027)

8.3.     North America Endometriosis Treatment by Countries

8.3.1.  North America Endometriosis Treatment Revenue and Growth Rate (2017-2027)

8.3.2.  North America Endometriosis Treatment Revenue (Million USD) by Countries (2017-2027)

8.3.3.  United States

8.3.3.1.  United States Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.4.  Canada

8.3.4.1.  Canada Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.3.5.  Mexico

8.3.5.1.  Mexico Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.     Europe Endometriosis Treatment by Countries

8.4.1.  Europe Endometriosis Treatment Revenue and Growth Rate (2017-2027)

8.4.2.  Europe Endometriosis Treatment Revenue (Million USD) by Countries (2017-2027)

8.4.3.  Germany

8.4.3.1.  Germany Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.4.  France

8.4.4.1.  France Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.5.  UK

8.4.5.1.  UK Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.6.  Russia

8.4.6.1.  Russia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.7.  Italy

8.4.7.1.  Italy Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.4.8.  Rest of Europe

8.4.8.1.  Rest of Europe Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.     Asia-Pacific Endometriosis Treatment by Countries

8.5.1.  Asia-Pacific Endometriosis Treatment Revenue and Growth Rate (2017-2027)

8.5.2.  Asia-Pacific Endometriosis Treatment Revenue (Million USD) by Countries (2017-2027)

8.5.3.  China

8.5.3.1.  China Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.4.  Japan

8.5.4.1.  Japan Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.5.  Korea

8.5.5.1.  Korea Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.6.  India

8.5.6.1.  India Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.7.  Southeast Asia

8.5.7.1.  Southeast Asia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.5.8.  Rest of Asia-Pacific

8.5.8.1.  Rest of Asia-Pacific Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.     South America Endometriosis Treatment by Countries

8.6.1.  South America Endometriosis Treatment Revenue and Growth Rate (2017-2027)

8.6.2.  South America Endometriosis Treatment Revenue (Million USD) by Countries (2017-2027)

8.6.3.  Brazil

8.6.3.1.  Brazil Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.4.  Argentina

8.6.4.1.  Argentina Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.5.  Columbia

8.6.5.1.  Columbia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.6.6.  Rest of South America

8.6.6.1.  Rest of South America Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.     Middle East and Africa Endometriosis Treatment by Countries

8.7.1.  Middle East and Africa Endometriosis Treatment Revenue and Growth Rate (2017-2027)

8.7.2.  Middle East and Africa Endometriosis Treatment Revenue (Million USD) by Countries (2017-2027)

8.7.3.  Saudi Arabia

8.7.3.1.  Saudi Arabia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.4.  United Arab Emirates

8.7.4.1.  United Arab Emirates Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.5.  Egypt

8.7.5.1.  Egypt Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.6.  Nigeria

8.7.6.1.  Nigeria Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.7.  South Africa

8.7.7.1.  South Africa Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.8.  Turkey

8.7.8.1.  Turkey Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

8.7.9.  Rest of Middle East and Africa

8.7.9.1.  Rest of Middle East and Africa Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

9.       Company Profiles

9.1.     Neurocrine Biosciences Inc

9.1.1.  Business Overview

9.1.2.   Service Portfolio

9.1.3.  Strategic Developments

9.1.4.   Revenue and Market Share

9.2.     Eli Lilly and company

9.2.1.  Business Overview

9.2.2.   Service Portfolio

9.2.3.  Strategic Developments

9.2.4.   Revenue and Market Share

9.3.     AstraZeneca Plc

9.3.1.  Business Overview

9.3.2.   Service Portfolio

9.3.3.  Strategic Developments

9.3.4.   Revenue and Market Share

9.4.     Bayer AG

9.4.1.  Business Overview

9.4.2.   Service Portfolio

9.4.3.  Strategic Developments

9.4.4.   Revenue and Market Share

9.5.     Pfizer Inc

9.5.1.  Business Overview

9.5.2.   Service Portfolio

9.5.3.  Strategic Developments

9.5.4.   Revenue and Market Share

9.6.     Meditrina Pharmaceuticals

9.6.1.  Business Overview

9.6.2.   Service Portfolio

9.6.3.  Strategic Developments

9.6.4.   Revenue and Market Share

9.7.     Astellas Pharma

9.7.1.  Business Overview

9.7.2.   Service Portfolio

9.7.3.  Strategic Developments

9.7.4.   Revenue and Market Share

9.8.     Abbvie

9.8.1.  Business Overview

9.8.2.   Service Portfolio

9.8.3.  Strategic Developments

9.8.4.   Revenue and Market Share

10.    Global Endometriosis Treatment Market Competition, by Manufacturer

10.1. Global Endometriosis Treatment Revenue and Market Share by Manufacturer (2017-2017)

10.2. Global Endometriosis Treatment Price By Region (2017-2017)

10.3. Top 5 Endometriosis Treatment Manufacturer Market Share

10.4. Market Competition Trend

11.    Endometriosis Treatment Market Forecast (2017-2027)

11.1. Global Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2027)

11.2. Endometriosis Treatment Market Forecast by Regions (2017-2027)

11.2.1.      North America Endometriosis Treatment Market Forecast (2017-2027)

11.2.1.1. United States Endometriosis Treatment Market Forecast (2017-2027)

11.2.1.2. Canada Endometriosis Treatment Market Forecast (2017-2027)

11.2.1.3. Mexico Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.      Europe Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.1. Germany Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.2. France Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.3. UK Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.4. Russia Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.5. Italy Endometriosis Treatment Market Forecast (2017-2027)

11.2.2.6. Rest of Europe Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.      Asia-Pacific Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.1. China Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.2. Japan Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.3. Korea Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.4. India Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.5. Southeast Asia Endometriosis Treatment Market Forecast (2017-2027)

11.2.3.6. Rest of Asia-Pacific Endometriosis Treatment Market Forecast (2017-2027)

11.2.4.      South America Endometriosis Treatment Market Forecast (2017-2027)

11.2.4.1. Brazil Endometriosis Treatment Market Forecast (2017-2027)

11.2.4.2. Argentina Endometriosis Treatment Market Forecast (2017-2027)

11.2.4.3. Columbia Endometriosis Treatment Market Forecast (2017-2027)

11.2.4.4. Rest of South America Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.      Middle East and Africa Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.1. Saudi Arabia Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.2. United Arab Emirates Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.3. Egypt Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.4. Nigeria Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.5. South Africa Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.6. Turkey Endometriosis Treatment Market Forecast (2017-2027)

11.2.5.7. Rest of Middle East and Africa Endometriosis Treatment Market Forecast (2017-2027)

11.3. Endometriosis Treatment Market Forecast by Drug Type (2017-2027)

11.3.1.      Endometriosis Treatment Forecast by Drug Type (2017-2027)

11.3.2.      Endometriosis Treatment Market Share Forecast by Drug Type (2017-2027)

11.4. Endometriosis Treatment Market Forecast by Treatment Type (2017-2027)

11.4.1.      Endometriosis Treatment Forecast by Treatment Type (2017-2027)

11.4.2.      Endometriosis Treatment Market Share Forecast by Treatment Type (2017-2027)

11.5. Endometriosis Treatment Market Forecast by Distribution Channel (2017-2027)

11.5.1.      Endometriosis Treatment Forecast by Distribution Channel (2017-2027)

11.5.2.      Endometriosis Treatment Market Share Forecast by Distribution Channel (2017-2027)

List of Tables

List of Tables and Figures

Figure United States Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Canada Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Mexico Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Germany Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure France Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure UK Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Russia Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Italy Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Europe Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure China Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Japan Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Korea Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure India Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Southeast Asia Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Asia-Pacific Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Brazil Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Argentina Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Columbia Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of South America Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Saudi Arabia Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure United Arab Emirates Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Egypt Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Nigeria Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure South Africa Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Turkey Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Figure Rest of Middle East and Africa Endometriosis Treatment Revenue (Million USD) and Growth Rate (2017-2025)

Table Global Endometriosis Treatment Revenue and Revenue Share by Drug Type (2017-2018)

Figure Global Progestin Revenue and Growth Rate (2017-2018)

Figure Global Gonadotropins Releasing Hormone agonists (GRH) Revenue and Growth Rate (2017-2018)

Figure Global Oral contraceptive pills Revenue and Growth Rate (2017-2018)

Figure Global Non-Steroidal Anti-Inflammatory drugs (NSAIDs) Revenue and Growth Rate (2017-2018)

Table Global Endometriosis Treatment Revenue and Revenue Share by Treatment Type (2017-2018)

Figure Global Hormonal Therapies Revenue and Growth Rate (2017-2018)

Figure Global Pain management Revenue and Growth Rate (2017-2018)

Table Global Endometriosis Treatment Revenue and Revenue Share by Distribution Channel (2017-2018)

Figure Global Mail Order Pharmacies Revenue and Growth Rate (2017-2018)

Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)

Figure Global E-commerce Revenue and Growth Rate (2017-2018)

Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)

Figure Global Drugstores Revenue and Growth Rate (2017-2018)

Figure Global Others Revenue and Growth Rate (2017-2018)

Table Global Endometriosis Treatment Revenue by Regions (2017-2018)

Figure North America Endometriosis Treatment Growth Rate (2017-2018)

Figure North America Endometriosis Treatment Revenue and Growth Rate (2017-2018)

Figure North America Endometriosis Treatment by Countries (2017-2018)

Figure North America Endometriosis Treatment Revenue (Million USD) by Countries (2017-2018)

Figure United States Endometriosis Treatment Growth Rate (2017-2018)

Figure United States Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Canada Endometriosis Treatment Growth Rate (2017-2018)

Figure Canada Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Mexico Endometriosis Treatment Growth Rate (2017-2018)

Figure Mexico Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Europe Endometriosis Treatment Growth Rate (2017-2018)

Figure Europe Endometriosis Treatment Revenue and Growth Rate (2017-2018)

Figure Europe Endometriosis Treatment by Countries (2017-2018)

Figure Europe Endometriosis Treatment Revenue (Million USD) by Countries (2017-2018)

Figure Germany Endometriosis Treatment Growth Rate (2017-2018)

Figure Germany Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure France Endometriosis Treatment Growth Rate (2017-2018)

Figure France Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure UK Endometriosis Treatment Growth Rate (2017-2018)

Figure UK Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Russia Endometriosis Treatment Growth Rate (2017-2018)

Figure Russia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Italy Endometriosis Treatment Growth Rate (2017-2018)

Figure Italy Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Europe Endometriosis Treatment Growth Rate (2017-2018)

Figure Rest of Europe Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Asia-Pacific Endometriosis Treatment Growth Rate (2017-2018)

Figure Asia-Pacific Endometriosis Treatment Revenue and Growth Rate (2017-2018)

Figure Asia-Pacific Endometriosis Treatment by Countries (2017-2018)

Figure Asia-Pacific Endometriosis Treatment Revenue (Million USD) by Countries (2017-2018)

Figure China Endometriosis Treatment Growth Rate (2017-2018)

Figure China Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Japan Endometriosis Treatment Growth Rate (2017-2018)

Figure Japan Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Korea Endometriosis Treatment Growth Rate (2017-2018)

Figure Korea Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure India Endometriosis Treatment Growth Rate (2017-2018)

Figure India Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Southeast Asia Endometriosis Treatment Growth Rate (2017-2018)

Figure Southeast Asia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Endometriosis Treatment Growth Rate (2017-2018)

Figure Rest of Asia-Pacific Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South America Endometriosis Treatment Growth Rate (2017-2018)

Figure South America Endometriosis Treatment Revenue and Growth Rate (2017-2018)

Figure South America Endometriosis Treatment by Countries (2017-2018)

Figure South America Endometriosis Treatment Revenue (Million USD) by Countries (2017-2018)

Figure Brazil Endometriosis Treatment Growth Rate (2017-2018)

Figure Brazil Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Argentina Endometriosis Treatment Growth Rate (2017-2018)

Figure Argentina Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Columbia Endometriosis Treatment Growth Rate (2017-2018)

Figure Columbia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of South America Endometriosis Treatment Growth Rate (2017-2018)

Figure Rest of South America Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Middle East and Africa Endometriosis Treatment Growth Rate (2017-2018)

Figure Middle East and Africa Endometriosis Treatment Revenue and Growth Rate (2017-2018)

Figure Middle East and Africa Endometriosis Treatment by Countries (2017-2018)

Figure Middle East and Africa Endometriosis Treatment Revenue (Million USD) by Countries (2017-2018)

Figure Saudi Arabia Endometriosis Treatment Growth Rate (2017-2018)

Figure Saudi Arabia Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure United Arab Emirates Endometriosis Treatment Growth Rate (2017-2018)

Figure United Arab Emirates Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Egypt Endometriosis Treatment Growth Rate (2017-2018)

Figure Egypt Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Nigeria Endometriosis Treatment Growth Rate (2017-2018)

Figure Nigeria Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure South Africa Endometriosis Treatment Growth Rate (2017-2018)

Figure South Africa Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Turkey Endometriosis Treatment Growth Rate (2017-2018)

Figure Turkey Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Endometriosis Treatment Growth Rate (2017-2018)

Figure Rest of Middle East and Africa Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2017-2018)

Table Neurocrine Biosciences Inc Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Eli Lilly and company Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table AstraZeneca Plc Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Bayer AG Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Pfizer Inc Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Meditrina Pharmaceuticals Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Astellas Pharma Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Table Abbvie Endometriosis Treatment Price, Revenue, Gross Margin and Market Share (2017-2017)

Figure Global Endometriosis Treatment Market Share by Manufacturer

Figure Global Endometriosis Treatment Revenue and Market Share by Manufacturer

Table Global Endometriosis Treatment Price by Region (2017-2017)

Figure Top 5 Endometriosis Treatment Manufacturer (Revenue) Market Share

Figure Market Competition Trend

Figure Global Endometriosis Treatment Revenue (Millions USD) and Growth Rate (2018-2025)

Table Endometriosis Treatment Market Forecast by Regions (2018-2025)

Figure North America Endometriosis Treatment Market Forecast (2018-2025)

Figure United States Endometriosis Treatment Market Forecast (2018-2025)

Figure Canada Endometriosis Treatment Market Forecast (2018-2025)

Figure Mexico Endometriosis Treatment Market Forecast (2018-2025)

Figure Europe Endometriosis Treatment Market Forecast (2018-2025)

Figure Germany Endometriosis Treatment Market Forecast (2018-2025)

Figure France Endometriosis Treatment Market Forecast (2018-2025)

Figure UK Endometriosis Treatment Market Forecast (2018-2025)

Figure Russia Endometriosis Treatment Market Forecast (2018-2025)

Figure Italy Endometriosis Treatment Market Forecast (2018-2025)

Figure Rest of Europe Endometriosis Treatment Market Forecast (2018-2025)

Figure Asia-Pacific Endometriosis Treatment Market Forecast (2018-2025)

Figure China Endometriosis Treatment Market Forecast (2018-2025)

Figure Japan Endometriosis Treatment Market Forecast (2018-2025)

Figure Korea Endometriosis Treatment Market Forecast (2018-2025)

Figure India Endometriosis Treatment Market Forecast (2018-2025)

Figure Southeast Asia Endometriosis Treatment Market Forecast (2018-2025)

Figure Rest of Asia-Pacific Endometriosis Treatment Market Forecast (2018-2025)

Figure South America Endometriosis Treatment Market Forecast (2018-2025)

Figure Brazil Endometriosis Treatment Market Forecast (2018-2025)

Figure Argentina Endometriosis Treatment Market Forecast (2018-2025)

Figure Columbia Endometriosis Treatment Market Forecast (2018-2025)

Figure Rest of South America Endometriosis Treatment Market Forecast (2018-2025)

Figure Middle East and Africa Endometriosis Treatment Market Forecast (2018-2025)

Figure Saudi Arabia Endometriosis Treatment Market Forecast (2018-2025)

Figure United Arab Emirates Endometriosis Treatment Market Forecast (2018-2025)

Figure Egypt Endometriosis Treatment Market Forecast (2018-2025)

Figure Nigeria Endometriosis Treatment Market Forecast (2018-2025)

Figure South Africa Endometriosis Treatment Market Forecast (2018-2025)

Figure Turkey Endometriosis Treatment Market Forecast (2018-2025)

Figure Rest of Middle East and Africa Endometriosis Treatment Market Forecast (2018-2025)

Figure Global Endometriosis Treatment Forecast by Drug Type (2018-2025)

Figure Global Endometriosis Treatment Market Share Forecast by Drug Type (2018-2025)

Figure Global Endometriosis Treatment Forecast by Drug Type (2018-2025)

Figure Global Endometriosis Treatment Forecast by Treatment Type (2018-2025)

Figure Global Endometriosis Treatment Market Share Forecast by Treatment Type (2018-2025)

Figure Global Endometriosis Treatment Forecast by Treatment Type (2018-2025)

Figure Global Endometriosis Treatment Forecast by Distribution Channel (2018-2025)

Figure Global Endometriosis Treatment Market Share Forecast by Distribution Channel (2018-2025)

Figure Global Endometriosis Treatment Forecast by Distribution Channel (2018-2025)

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources
  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources
  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)
  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*